Skip to main content

Advertisement

SpringerLink
Log in

Assessment of Subconjunctival Delivery with Model Ionic Permeants and Magnetic Resonance Imaging

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

No Heading

Purpose.

The objective was to assess the permeation and clearance of model ionic permeants after subconjunctival injection with nuclear magnetic resonance imaging (MRI).

Methods.

New Zealand white rabbit was the animal model and manganese ion (Mn2+) and manganese ethylenediaminetetraacetic acid complex (MnEDTA2−) were the model permeants. The current study was divided into three parts: in vitro, postmortem, and in vivo. Transscleral passive permeation experiments were conducted with excised sclera in side-by-side diffusion cells in vitro. Subconjunctival delivery experiments were conducted with rabbits postmortem and in vivo. The distribution and elimination of the probe permeants from the subconjunctival space after subconjunctival injections were determined by MRI.

Results.

The data of excised sclera in vitro suggest large effective pore size for transscleral transport and negligible pore charge effects upon the permeation of the ionic permeants. The permeability coefficients of Mn2+ and MnEDTA2- across the sclera in vitro were 3.6 × 10-5 cm/s and 2.4 × 10-5 cm/s, respectively. Although relatively high sclera permeability was observed in vitro, subconjunctival injections in vivo did not provide significant penetration of Mn2+ and MnEDTA2- into the globe; permeant concentrations in the eye were below the detection limit, which corresponds to less than 0.05% of the concentration of the injection solution (e.g., less than 0.02 mM when 40 mM injection solution was used). The volume of the subconjunctival pocket and the concentration of the permeants in the pocket were observed to decrease with time after the injection, and this could contribute to the lower than expected subconjunctival absorption in vivo. Different from the results in vivo, experiments with rabbits postmortem show significant penetration of Mn2+ and MnEDTA2- into the globe with the permeants primarily delivered into the anterior segment of the eye. This difference suggests blood vasculature clearance as a main barrier for passive transscleral transport. The data also show that the pars plicata/pars plana is the least resistance pathway for passive transscleral drug delivery of the polar permeants, and there are indications of the presence of another barrier, possibly the retinal epithelium and/or Bruch’s membrane, at the back of the eye.

Conclusions.

Subconjunctival delivery of the ionic permeants in vivo cannot be quantitatively predicted by the in vitro results. MRI is a noninvasive complementary technique to traditional pharmacokinetic methods. It can provide insights into ocular pharmacokinetics without permeant redistribution that can occur in surgical procedure postmortem in traditional pharmacokinetic studies when the blood vasculature barrier is absent.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. 1. T. W. Kim, J. D. Lindsey, M. Aihara, T. L. Anthony, and R. N. Weinreb. Intraocular distribution of 70-kDa dextran after subconjunctival injection in mice. Invest. Ophthalmol. Vis. Sci. 43:1809–1816 (2002).

    Google Scholar 

  2. 2. Y. Yanagi, Y. Tamaki, R. Obata, K. Muranaka, N. Homma, H. Matsuoka, and H. Mano. Subconjunctival administration of bucillamine suppresses choroidal neovascularization in rat. Invest. Ophthalmol. Vis. Sci. 43:3495–3499 (2002).

    Google Scholar 

  3. 3. U. B. Kompella, N. Bandi, and S. P. Ayalasomayajula. Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression. Invest. Ophthalmol. Vis. Sci. 44:1192–1201 (2003).

    Google Scholar 

  4. 4. N. Worakul and J. R. Robinson. Ocular pharmacokinetics/pharmacodynamics. Eur. J. Pharm. Biopharm. 44:71–83 (1997).

    Google Scholar 

  5. 5. T. J. Zimmerman, K. S. Kooner, M. Sharir, and R. D. Fechtner. Textbook of Ocular Pharmacology, Lippincoot-Raven, Philadelphia, 1997.

    Google Scholar 

  6. 6. D. H. Geroski and H. F. Edelhauser. Transscleral drug delivery for posterior segment disease. Adv. Drug Deliv. Rev. 52:37–48 (2001).

    Google Scholar 

  7. 7. M. R. Prausnitz and J. S. Noonan. Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. J. Pharm. Sci. 87:1479–1488 (1998).

    Google Scholar 

  8. 8. J. Ambati, C. S. Canakis, J. W. Miller, E. S. Gragoudas, A. Edwards, D. J. Weissgold, I. Kim, F. C. Delori, and A. P. Adamis. Diffusion of high molecular weight compounds through sclera. Invest. Ophthalmol. Vis. Sci. 41:1181–1185 (2000).

    Google Scholar 

  9. 9. A. K. Mitra. Ophthalmic Drug Delivery Systems, Marcel Dekker, New York, 1993.

    Google Scholar 

  10. 10. Y. Ogura. Drug delivery to the posterior segments of the eye. Adv. Drug Deliv. Rev. 52:1–3 (2001).

    Google Scholar 

  11. 11. T. W. Lee and J. R. Robinson. Drug delivery to the posterior segment of the eye II: development and validation of a simple pharmacokinetic model for subconjunctival injection. J. Ocul. Pharmacol. Ther. 20:43–53 (2004).

    Google Scholar 

  12. 12. T. W. Lee and J. R. Robinson. Drug delivery to the posterior segment of the eye III: the effect of parallel elimination pathway on the vitreous drug level after subconjunctival injection. J. Ocul. Pharmacol. Ther. 20:55–64 (2004).

    Google Scholar 

  13. 13. S. K. Li, E. K. Jeong, and M. S. Hastings. Magnetic resonance imaging study of current and ion delivery into the eye during transscleral and transcorneal iontophoresis. Invest. Ophthalmol. Vis. Sci. 45:1224–1231 (2004).

    Google Scholar 

  14. 14. D. D. Stark and W. G. Bradley. Magnetic Resonance Imaging, 2nd ed. Mosbey Year Book, Boston, 1992, Ch. 14.

    Google Scholar 

  15. 15. T. Watanabe, T. Michaelis, and J. Frahm. Mapping of retinal projections in the living rat using high-resolution 3D gradient-echo MRI with Mn2+-induced contrast. Magn. Reson. Med. 46:424–429 (2001).

    Google Scholar 

  16. 16. R. G. Pautler, R. Mongeau, and R. E. Jacobs. In vivo trans-synaptic tract tracing from the murine striatum and amygdala utilizing manganese enhanced MRI (MEMRI). Magn. Reson. Med. 50:33–39 (2003).

    Google Scholar 

  17. 17. K. D. Peck, A. H. Ghanem, and W. I. Higuchi. Hindered diffusion of polar molecules through and effective pore radii estimates of intact and ethanol treated human epidermal membrane. Pharm. Res. 11:1306–1314 (1994).

    Google Scholar 

  18. 18. D. R. Lide. CRC Handbook for Chemistry and Physics, CRC Press, New York, 2004.

    Google Scholar 

  19. 19. S. K. Li, A. H. Ghanem, K. D. Peck, and W. I. Higuchi. Iontophoretic transport across a synthetic membrane and human epidermal membrane: a study of the effects of permeant charge. J. Pharm. Sci. 86:680–689 (1997).

    Google Scholar 

  20. 20. D. E. Rudnick, J. S. Noonan, D. H. Geroski, M. R. Prausnitz, and H. F. Edelhauser. The effect of intraocular pressure on human and rabbit scleral permeability. Invest. Ophthalmol. Vis. Sci. 40:3054–3058 (1999).

    Google Scholar 

  21. 21. M. E. Yablonski, M. Hayashi, D. J. Cook, G. Chubak, and M. Sirota. Fluorophotometric study of intravenous carbonic anhydrase inhibitors in rabbits. Invest. Ophthalmol. Vis. Sci. 28:2076–2082 (1987).

    Google Scholar 

  22. 22. H. M. Cheng, K. K. Kwong, J. Xiong, and C. Chang. GdDTPA-enhanced magnetic resonance imaging of the aqueous flow in the rabbit eye. Magn. Reson. Med. 17:237–243 (1991).

    Google Scholar 

  23. 23. M. Barza and M. McCue. Pharmacokinetics of aztreonam in rabbit eyes. Antimicrob. Agents Chemother. 24:468–473 (1983).

    Google Scholar 

  24. 24. W. M. Jay, R. K. Shockley, A. M. Aziz, M. Z. Aziz, and J. P. Rissing. Ocular pharmacokinetics of ceftriaxone following subconjunctival injection in rabbits. Arch. Ophthalmol. 102:430–432 (1984).

    Google Scholar 

  25. 25. S. Marrakchi-Benjaafar, I. Cochereau, F. D’Hermies, and J. J. Pocidalo. Tolerability, kinetics, and efficacy of subconjunctival pefloxacin in pigmented rabbits. Antimicrob. Agents Chemother. 39:834–838 (1995).

    Google Scholar 

  26. 26. D. P. Hainsworth, J. D. Conklin, J. R. Bierly, D. Ax, and P. Ashton. Intravitreal delivery of ciprofloxacin. J. Ocul. Pharmacol. Ther. 12:183–191 (1996).

    Google Scholar 

  27. 27. G. S. Kalsi, G. Gudauskas, N. Bussanich, D. J. Freeman, and J. Rootman. Ocular pharmacokinetics of subconjunctivally administered cyclosporine in the rabbit. Can. J. Ophthalmol. 26:200–205 (1991).

    Google Scholar 

  28. 28. M. Barza, A. Kane, and J. L. Baum. Intraocular levels of cefamandole compared with cefazolin after subconjunctival injection in rabbits. Invest. Ophthalmol. Vis. Sci. 18:250–255 (1979).

    Google Scholar 

  29. 29. E. F. Erkin, U. Gunenc, F. H. Oner, A. Gelal, Y. Erkin, and H. Guven. Penetration of amikacin into aqueous humor of rabbits. Ophthalmologica 215:299–302 (2001).

    Google Scholar 

  30. 30. M. Souli, G. Kopsinis, E. Kavouklis, L. Gabriel, and H. Giamarellou. Vancomycin levels in human aqueous humour after intravenous and subconjunctival administration. Int. J. Antimicrob. Agents 18:239–243 (2001).

    Google Scholar 

  31. 31. T. W. Lee and J. R. Robinson. Drug delivery to the posterior segment of the eye: some insights on the penetration pathways after subconjunctival injection. J. Ocul. Pharmacol. Ther. 17:565–572 (2001).

    Google Scholar 

  32. 32. W. S. Foulds, D. Allan, H. Moseley, and P. M. Kyle. Effect of intravitreal hyaluronidase on the clearance of tritiated water from the vitreous to the choroid. Br. J. Ophthalmol. 69:529–532 (1985).

    Google Scholar 

  33. 33. B. A. Berkowitz, C. A. Wilson, P. S. Tofts, and R. M. Peshock. Effect of vitreous fluidity on the measurement of blood-retinal barrier permeability using contrast-enhanced MRI. Magn. Reson. Med. 31:61–66 (1994).

    Google Scholar 

  34. 34. T. L. Jackson, R. J. Antcliff, J. Hillenkamp, and J. Marshall. Human retinal molecular weight exclusion limit and estimate of species variation. Invest. Ophthalmol. Vis. Sci. 44:2141–2146 (2003).

    Google Scholar 

  35. 35. B. A. Berkowitz, P. S. Tofts, H. A. Sen, N. Ando, and E. de Juan Jr. Accurate and precise measurement of blood-retinal barrier breakdown using dynamic Gd-DTPA MRI. Invest. Ophthalmol. Vis. Sci. 33:3500–3506 (1992).

    Google Scholar 

  36. 36. N. Alikacem, T. Yoshizawa, K. D. Nelson, and C. A. Wilson. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits. Invest. Ophthalmol. Vis. Sci. 41:1561–1569 (2000).

    Google Scholar 

  37. 37. H. Kim, M. R. Robinson, M. J. Lizak, G. Tansey, R. J. Lutz, P. Yuan, N. S. Wang, and K. G. Csaky. Controlled drug release from an ocular implant: an evaluation using dynamic 3-dimensional magnetic resonance imaging. Invest. Ophthalmol. Vis. Sci. 45:2722–2731 (2004).

    Google Scholar 

  38. 38. A. F. Holleman and E. Wiberg. Inorganic Chemistry, Academic Press, New York, 2001, Ch. 20.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, Utah, 84112, USA

    S. Kevin Li & Sarah A. Molokhia

  2. Department of Radiology and Utah Center for Advanced Imaging Research, University of Utah, Salt Lake City, Utah, 84108, USA

    Eun-Kee Jeong

Authors
  1. S. Kevin Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sarah A. Molokhia
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eun-Kee Jeong
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Kevin Li.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, S., Molokhia, S. & Jeong, EK. Assessment of Subconjunctival Delivery with Model Ionic Permeants and Magnetic Resonance Imaging. Pharm Res 21, 2175–2184 (2004). https://doi.org/10.1007/s11095-004-7669-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-004-7669-3

Key words:

Search

Navigation